Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value trap?
Price charts only tell part of the story. Our team at StockStory evaluates each company's underlying fundamentals to separate temporary setbacks from structural declines. Keeping that in mind, here are three stocks where the skepticism is well-placed and some better opportunities to consider.
Jack in the Box (JACK)
One-Month Return: -32.3%
Delighting customers since its inception in 1951, Jack in the Box (NASDAQ: JACK) is a distinctive fast-food chain known for its bold flavors, innovative menu items, and quirky marketing.
Why Should You Dump JACK?
- Poor same-store sales performance over the past two years indicates it’s having trouble bringing new diners into its restaurants
- Costs have risen faster than its revenue over the last year, causing its operating margin to decline by 9.3 percentage points
- High net-debt-to-EBITDA ratio of 11× could force the company to raise capital at unfavorable terms if market conditions deteriorate
Jack in the Box is trading at $11.38 per share, or 3x forward P/E. If you’re considering JACK for your portfolio, see our FREE research report to learn more.
Zevia (ZVIA)
One-Month Return: -25.5%
With a primary focus on soda but also a presence in energy drinks and teas, Zevia (NYSE: ZVIA) is a better-for-you beverage company.
Why Does ZVIA Give Us Pause?
- Products fail to spark excitement with consumers, as seen in its flat sales over the last three years
- Subscale operations are evident in its revenue base of $161.3 million, meaning it has fewer distribution channels than its larger rivals
- Poor expense management has led to operating margin losses
At $1.24 per share, Zevia trades at 0.5x forward price-to-sales. To fully understand why you should be careful with ZVIA, check out our full research report (it’s free).
MetLife (MET)
One-Month Return: -13.3%
Founded in 1863 by a group of New York businessmen during the Civil War era, MetLife (NYSE: MET) is a global financial services company that provides insurance, annuities, employee benefits, and asset management services to individuals and businesses worldwide.
Why Do We Think MET Will Underperform?
- Net premiums earned only expanded by 2.8% annually over the last five years, trailing its insurance peers as its scale limited incremental business
- Earnings growth over the last two years fell short of the peer group average as its EPS only increased by 10.3% annually
- Policy losses and capital returns have eroded its book value per share this cycle as its book value per share declined by 12.3% annually over the last five years
MetLife’s stock price of $68.60 implies a valuation ratio of 1.6x forward P/B. Check out our free in-depth research report to learn more about why MET doesn’t pass our bar.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it's flagging for this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
